Analysis of COVID-19 prevention and treatment in Taiwan.
Coronavirus disease 2019 (COVID-19)
Name-based mask distribution system (NBMDS)
Preventive strategy
Respiratory Syndrome coronavirus 2 (SARS-CoV-2)
Therapeutic agents
Journal
BioMedicine
ISSN: 2211-8020
Titre abrégé: Biomedicine (Taipei)
Pays: China (Republic : 1949- )
ID NLM: 101611451
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
12
2020
revised:
15
12
2020
accepted:
16
12
2020
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
1
3
2022
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) has been spreading worldwide with a mind-boggling speed. According to a statement from World Health Organization (WHO), COVID-19 has infected more than six billions people and caused more than one and half million passing in the world. Based on previous experience with SARS, the Taiwanese government had decided to block viral transmission during its early stages. This review sums up the clinical characteristics, Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) viral infection process, diagnostic methods, preventive strategy, and the executive proportions of COVID-19, as well as the name-based mask distribution system (NBMDS) in Taiwan. We also give a review of the conceivable sub-atomic pharmacologic systems against SARS-CoV-2 specialists and the blend of remdesivir (GS-5734), chloroquine (CQ), and hydroxychloroquine (HCQ). Lastly, we summarized the therapeutic agents against COVID-19 as mentioned by COVID-19 treatment guidelines. In this review, development of novel anti-SARS-CoV-2 viral agents, vaccines for COVID-19 therapy or an effective combination therapy can be expected based on all the information accumulated. Last but not least, we might want to stretch out our best respects to all medical providers in their worldwide battle against COVID-19.
Identifiants
pubmed: 35223390
doi: 10.37796/2211-8039.1185
pii: bmed-11-01-001
pmc: PMC8823471
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1-18Informations de copyright
© the Author(s).
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no competing interests.
Références
Radiol Infect Dis. 2020 Sep;7(3):130-134
pubmed: 32838009
J Hosp Infect. 2020 Jun;105(2):358-359
pubmed: 32277965
J Med Chem. 2017 Mar 9;60(5):1648-1661
pubmed: 28124907
Science. 2020 Mar 27;367(6485):1412-1413
pubmed: 32217705
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
J Chin Med Assoc. 2020 Sep;83(9):805-808
pubmed: 32520770
Curr Pharmacol Rep. 2020;6(4):146-154
pubmed: 32837851
Bioeng Transl Med. 2020 Aug 13;:e10177
pubmed: 32838038
Cont Lens Anterior Eye. 2020 Jun;43(3):196-203
pubmed: 32273245
Biomed J. 2020 Aug;43(4):341-354
pubmed: 32532623
Mol Cell Biochem. 2021 Feb;476(2):553-574
pubmed: 33029696
Diagn Interv Radiol. 2021 Sep;27(5):621-632
pubmed: 33135665
J Microbiol Immunol Infect. 2021 Feb;54(1):17-26
pubmed: 33153907
Biomed Environ Sci. 2006 Jun;19(3):173-8
pubmed: 16944772
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Clin Chem Lab Med. 2020 Jun 25;58(7):1100-1105
pubmed: 32573995
Alcohol Alcohol. 2020 Jun 25;55(4):354-356
pubmed: 32400852
Pan Afr Med J. 2020 Sep 08;37:32
pubmed: 33209159
ACS Infect Dis. 2020 Jul 10;6(7):1553-1557
pubmed: 32412231
Kaohsiung J Med Sci. 2020 May;36(5):296-304
pubmed: 32374901
Photochem Photobiol Sci. 2020 Jun;19(6):746-751
pubmed: 33856682
Influenza Other Respir Viruses. 2020 Jul;14(4):365-373
pubmed: 32246890
Chin Med Sci J. 2020 Sep 30;35(3):254-261
pubmed: 32972503
Infect Control Hosp Epidemiol. 2020 Nov;41(11):1360-1361
pubmed: 32319881
J Histotechnol. 2020 Jun;43(2):102-104
pubmed: 32116147
J Chin Med Assoc. 2020 Sep;83(9):822-824
pubmed: 32618600
World J Emerg Surg. 2020 Jun 30;15(1):41
pubmed: 32605582
Infect Control Hosp Epidemiol. 2007 May;28(5):525-30
pubmed: 17464910
Sci Total Environ. 2020 Aug 1;728:138870
pubmed: 32335408
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
Eur J Pharmacol. 2021 Feb 5;892:173751
pubmed: 33245898
Eur J Pharmacol. 2020 Sep 15;883:173372
pubmed: 32682787
J Am Chem Soc. 1946 Jul;68:1204-8
pubmed: 20990951
Cost Eff Resour Alloc. 2020 Oct 19;18:45
pubmed: 33088224
Front Public Health. 2020 Oct 21;8:547423
pubmed: 33194949
Int J Mol Med. 2021 Jan;47(1):3-22
pubmed: 33236131
J Evid Based Med. 2020 May;13(2):93-101
pubmed: 32167245
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Jun 30;40(6):778-785
pubmed: 32895195
J Med Virol. 2020 Sep;92(9):1567-1571
pubmed: 32232986
Knee Surg Sports Traumatol Arthrosc. 2020 Jun;28(6):1690-1698
pubmed: 32342138
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Mar 30;40(3):342-345
pubmed: 32376593
J Am Chem Soc. 1946 Jul;68:1214-6
pubmed: 20990953
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105182
pubmed: 33066878
Med Sci Monit. 2020 Sep 25;26:e925974
pubmed: 32973126
J Med Internet Res. 2020 Nov 20;22(11):e21501
pubmed: 33119536
Hu Li Za Zhi. 2020 Jun;67(3):84-89
pubmed: 32495333
Cochrane Database Syst Rev. 2020 Apr 15;4:CD011621
pubmed: 32293717
Pediatr Radiol. 2021 Feb;51(2):239-247
pubmed: 32945888